Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 450

1.

Toward New Classification Criteria for Juvenile Idiopathic Arthritis: First Steps, Pediatric Rheumatology International Trials Organization International Consensus.

Martini A, Ravelli A, Avcin T, Beresford MW, Burgos-Vargas R, Cuttica R, Ilowite NT, Khubchandani R, Laxer RM, Lovell DJ, Petty RE, Wallace CA, Wulffraat NM, Pistorio A, Ruperto N; Pediatric Rheumatology International Trials Organization (PRINTO).

J Rheumatol. 2018 Oct 1. pii: jrheum.180168. doi: 10.3899/jrheum.180168. [Epub ahead of print]

2.

Juvenile arthritis management in less resourced countries (JAMLess): consensus recommendations from the Cradle of Humankind.

Scott C, Chan M, Slamang W, Okong'o L, Petty R, Laxer RM, Katsicas MM, Fredrick F, Chipeta J, Faller G, Pileggi G, Saad-Magalhaes C, Wouters C, Foster HE, Kubchandani R, Ruperto N, Russo R.

Clin Rheumatol. 2018 Sep 28. doi: 10.1007/s10067-018-4304-y. [Epub ahead of print]

PMID:
30267356
3.

Clustering of behavioural risk factors for health in UK adults in 2016: a cross-sectional survey.

Birch J, Petty R, Hooper L, Bauld L, Rosenberg G, Vohra J.

J Public Health (Oxf). 2018 Sep 6. doi: 10.1093/pubmed/fdy144. [Epub ahead of print]

PMID:
30192965
4.

De novo repeat interruptions are associated with reduced somatic instability and mild or absent clinical features in myotonic dystrophy type 1.

Cumming SA, Hamilton MJ, Robb Y, Gregory H, McWilliam C, Cooper A, Adam B, McGhie J, Hamilton G, Herzyk P, Tschannen MR, Worthey E, Petty R, Ballantyne B; Scottish Myotonic Dystrophy Consortium, Warner J, Farrugia ME, Longman C, Monckton DG.

Eur J Hum Genet. 2018 Nov;26(11):1635-1647. doi: 10.1038/s41431-018-0156-9. Epub 2018 Jul 2.

PMID:
29967337
5.

Pembrolizumab versus paclitaxel in gastro-oesophageal adenocarcinoma.

Smyth EC, Petty RD.

Lancet. 2018 Jul 14;392(10142):97-98. doi: 10.1016/S0140-6736(18)31277-7. Epub 2018 Jun 4. No abstract available.

PMID:
29880232
6.

Where Did This Thought Come From? A Self-Validation Analysis of the Perceived Origin of Thoughts.

Gascó M, Briñol P, Santos D, Petty RE, Horcajo J.

Pers Soc Psychol Bull. 2018 Nov;44(11):1615-1628. doi: 10.1177/0146167218775696. Epub 2018 Jun 4.

PMID:
29862884
7.

The Application of Persuasion Theory to Placebo Effects.

Geers AL, Briñol P, Vogel EA, Aspiras O, Caplandies FC, Petty RE.

Int Rev Neurobiol. 2018;138:113-136. doi: 10.1016/bs.irn.2018.01.004. Epub 2018 Feb 23.

PMID:
29681321
8.

Affective and cognitive validation of thoughts: An appraisal perspective on anger, disgust, surprise, and awe.

Briñol P, Petty RE, Stavraki M, Lamprinakos G, Wagner B, Díaz D.

J Pers Soc Psychol. 2018 May;114(5):693-718. doi: 10.1037/pspa0000118.

PMID:
29672103
9.

Aspirin Dose in Kawasaki Disease: The Ongoing Battle.

Dhanrajani A, Chan M, Pau S, Ellsworth J, Petty R, Guzman J.

Arthritis Care Res (Hoboken). 2018 Oct;70(10):1536-1540. doi: 10.1002/acr.23504. Epub 2018 Sep 7.

PMID:
29287309
10.

A randomized, open-label study of the efficacy and safety of AZD4547 monotherapy versus paclitaxel for the treatment of advanced gastric adenocarcinoma with FGFR2 polysomy or gene amplification.

Van Cutsem E, Bang YJ, Mansoor W, Petty RD, Chao Y, Cunningham D, Ferry DR, Smith NR, Frewer P, Ratnayake J, Stockman PK, Kilgour E, Landers D.

Ann Oncol. 2017 Jun 1;28(6):1316-1324. doi: 10.1093/annonc/mdx107.

PMID:
29177434
11.

Alexander Thom (1775-1845): From Army Surgeon to Settlement Founder.

Petty RD.

J Med Biogr. 2017 Jan 1:967772017729327. doi: 10.1177/0967772017729327. [Epub ahead of print]

PMID:
28972443
12.

Growth and weight gain in children with juvenile idiopathic arthritis: results from the ReACCh-Out cohort.

Guzman J, Kerr T, Ward LM, Ma J, Oen K, Rosenberg AM, Feldman BM, Boire G, Houghton K, Dancey P, Scuccimarri R, Bruns A, Huber AM, Watanabe Duffy K, Shiff NJ, Berard RA, Levy DM, Stringer E, Morishita K, Johnson N, Cabral DA, Larché M, Petty RE, Laxer RM, Silverman E, Miettunen P, Chetaille AL, Haddad E, Spiegel L, Turvey SE, Schmeling H, Lang B, Ellsworth J, Ramsey SE, Roth J, Campillo S, Benseler S, Chédeville G, Schneider R, Tse SML, Bolaria R, Gross K, Feldman D, Cameron B, Jurencak R, Dorval J, LeBlanc C, St Cyr C, Gibbon M, Yeung RSM, Duffy CM, Tucker LB.

Pediatr Rheumatol Online J. 2017 Aug 22;15(1):68. doi: 10.1186/s12969-017-0196-7.

13.

Gefitinib and EGFR Gene Copy Number Aberrations in Esophageal Cancer.

Petty RD, Dahle-Smith A, Stevenson DAJ, Osborne A, Massie D, Clark C, Murray GI, Dutton SJ, Roberts C, Chong IY, Mansoor W, Thompson J, Harrison M, Chatterjee A, Falk SJ, Elyan S, Garcia-Alonso A, Fyfe DW, Wadsley J, Chau I, Ferry DR, Miedzybrodzka Z.

J Clin Oncol. 2017 Jul 10;35(20):2279-2287. doi: 10.1200/JCO.2016.70.3934. Epub 2017 May 24.

PMID:
28537764
14.

The UK Myotonic Dystrophy Patient Registry: facilitating and accelerating clinical research.

Wood L, Cordts I, Atalaia A, Marini-Bettolo C, Maddison P, Phillips M, Roberts M, Rogers M, Hammans S, Straub V, Petty R, Orrell R, Monckton DG, Nikolenko N, Jimenez-Moreno AC, Thompson R, Hilton-Jones D, Turner C, Lochmüller H.

J Neurol. 2017 May;264(5):979-988. doi: 10.1007/s00415-017-8483-2. Epub 2017 Apr 10.

15.

Clinical Features, Molecular Heterogeneity, and Prognostic Implications in YARS2-Related Mitochondrial Myopathy.

Sommerville EW, Ng YS, Alston CL, Dallabona C, Gilberti M, He L, Knowles C, Chin SL, Schaefer AM, Falkous G, Murdoch D, Longman C, de Visser M, Bindoff LA, Rawles JM, Dean JCS, Petty RK, Farrugia ME, Haack TB, Prokisch H, McFarland R, Turnbull DM, Donnini C, Taylor RW, Gorman GS.

JAMA Neurol. 2017 Jun 1;74(6):686-694. doi: 10.1001/jamaneurol.2016.4357.

16.

Correction: Elevated plasma levels of cardiac troponin-I predict left ventricular systolic dysfunction in patients with myotonic dystrophy type 1: A multicentre cohort follow-up study.

Hamilton MJ, Robb Y, Cumming S, Gregory H, Duncan A, Rahman M, McKeown A, McWilliam C, Dean J, Wilcox A, Farrugia ME, Cooper A, McGhie J, Adam B, Petty R; Scottish Myotonic Dystrophy Consortium, Longman C, Findlay I, Japp A, Monckton DG, Denvir MA.

PLoS One. 2017 Apr 6;12(4):e0175615. doi: 10.1371/journal.pone.0175615. eCollection 2017.

17.

Elevated plasma levels of cardiac troponin-I predict left ventricular systolic dysfunction in patients with myotonic dystrophy type 1: A multicentre cohort follow-up study.

Hamilton MJ, Robb Y, Cumming S, Gregory H, Duncan A, Rahman M, McKeown A, McWilliam C, Dean J, Wilcox A, Farrugia ME, Cooper A, McGhie J, Adam B, Petty R; Scottish Myotonic Dystrophy Consortium, Longman C, Findlay I, Japp A, Monckton DG, Denvir MA.

PLoS One. 2017 Mar 21;12(3):e0174166. doi: 10.1371/journal.pone.0174166. eCollection 2017. Erratum in: PLoS One. 2017 Apr 6;12 (4):e0175615.

18.

Objectification of people and thoughts: An attitude change perspective.

Briñol P, Petty RE, Belding J.

Br J Soc Psychol. 2017 Jun;56(2):233-249. doi: 10.1111/bjso.12183. Epub 2017 Feb 11. Review.

PMID:
28188637
19.

Clinical Orofacial Examination in Juvenile Idiopathic Arthritis: International Consensus-based Recommendations for Monitoring Patients in Clinical Practice and Research Studies.

Stoustrup P, Twilt M, Spiegel L, Kristensen KD, Koos B, Pedersen TK, Küseler A, Cron RQ, Abramowicz S, Verna C, Peltomäki T, Alstergren P, Petty R, Ringold S, Nørholt SE, Saurenmann RK, Herlin T; euroTMjoint Research Network.

J Rheumatol. 2017 Mar;44(3):326-333. doi: 10.3899/jrheum.160796. Epub 2017 Jan 15. Review.

PMID:
28089967
20.

The importance of considering monogenic causes of autoimmunity: A somatic mutation in KRAS causing pediatric Rosai-Dorfman syndrome and systemic lupus erythematosus.

Ragotte RJ, Dhanrajani A, Pleydell-Pearce J, Del Bel KL, Tarailo-Graovac M, van Karnebeek C, Terry J, Senger C, McKinnon ML, Seear M, Prendiville JS, Tucker LB, Houghton K, Cabral DA, Guzman J, Petty RE, Brown KL, Tekano J, Wu J, Morishita KA, Turvey SE.

Clin Immunol. 2017 Feb;175:143-146. doi: 10.1016/j.clim.2016.12.006. Epub 2016 Dec 31.

PMID:
28043923
21.

The neuroscience of persuasion: A review with an emphasis on issues and opportunities.

Cacioppo JT, Cacioppo S, Petty RE.

Soc Neurosci. 2018 Apr;13(2):129-172. doi: 10.1080/17470919.2016.1273851. Epub 2017 Jan 9. Review.

PMID:
28005461
22.

From Power to Inaction.

Durso GR, Briñol P, Petty RE.

Psychol Sci. 2016 Dec;27(12):1660-1666. doi: 10.1177/0956797616669947. Epub 2016 Oct 23.

PMID:
27770058
23.

Wanting to Be Different Predicts Nonmotivated Change: Actual-Desired Self-Discrepancies and Susceptibility to Subtle Change Inductions.

DeMarree KG, Rios K, Randell JA, Wheeler SC, Reich DA, Petty RE.

Pers Soc Psychol Bull. 2016 Dec;42(12):1709-1722. Epub 2016 Oct 14.

PMID:
27742840
24.

Management of Juvenile Idiopathic Arthritis 2015: A Position Statement from the Pediatric Committee of the Canadian Rheumatology Association.

Cellucci T, Guzman J, Petty RE, Batthish M, Benseler SM, Ellsworth JE, Houghton KM, LeBLANC CM, Huber AM, Luca N, Schmeling H, Shiff NJ, Soon GS, Tse SM; Pediatric Committee of the Canadian Rheumatology Association.

J Rheumatol. 2016 Oct;43(10):1773-1776. Review. No abstract available.

PMID:
27698103
25.

Prognostic RNAs in oesophageal squamous cell carcinoma: small is beautiful.

Tan P, Petty R.

Gut. 2017 Feb;66(2):210-211. doi: 10.1136/gutjnl-2016-312585. Epub 2016 Sep 15. No abstract available.

PMID:
27633924
26.

Tumour expression of leptin is associated with chemotherapy resistance and therapy-independent prognosis in gastro-oesophageal adenocarcinomas.

Bain GH, Collie-Duguid E, Murray GI, Gilbert FJ, Denison A, Mckiddie F, Ahearn T, Fleming I, Leeds J, Phull P, Park K, Nanthakumaran S, Matula KM, Grabsch HI, Tan P, Welch A, Schweiger L, Dahle-Smith A, Urquhart G, Finegan M, Petty RD.

Br J Cancer. 2016 Jun 14;114(12):e18. doi: 10.1038/bjc.2016.139. Epub 2016 May 26. No abstract available.

27.

Clinical features of the myasthenic syndrome arising from mutations in GMPPB.

Rodríguez Cruz PM, Belaya K, Basiri K, Sedghi M, Farrugia ME, Holton JL, Liu WW, Maxwell S, Petty R, Walls TJ, Kennett R, Pitt M, Sarkozy A, Parton M, Lochmüller H, Muntoni F, Palace J, Beeson D.

J Neurol Neurosurg Psychiatry. 2016 Aug;87(8):802-9. doi: 10.1136/jnnp-2016-313163. Epub 2016 May 4.

28.

A Family History of Psoriasis in a First-degree Relative in Children with JIA: to Include or Exclude?

Chan MO, Petty RE, Guzman J; ReACCh-Out Investigators.

J Rheumatol. 2016 May;43(5):944-7. doi: 10.3899/jrheum.150555. Epub 2016 Mar 15.

PMID:
26980584
29.
30.

Phase Ib/II study of elisidepsin in metastatic or advanced gastroesophageal cancer (IMAGE trial).

Petty R, Anthoney A, Metges JP, Alsina M, Gonçalves A, Brown J, Montagut C, Gunzer K, Laus G, Iglesias Dios JL, Miguel-Lillo B, Bohan P, Salazar R.

Cancer Chemother Pharmacol. 2016 Apr;77(4):819-27. doi: 10.1007/s00280-016-2991-0. Epub 2016 Mar 10.

PMID:
26964995
31.

Tumour expression of leptin is associated with chemotherapy resistance and therapy-independent prognosis in gastro-oesophageal adenocarcinomas.

Bain GH, Collie-Duguid E, Murray GI, Gilbert FJ, Denison A, Mckiddie F, Ahearn T, Fleming I, Leeds J, Phull P, Park K, Nanthakumaran S, Matula KM, Grabsch HI, Tan P, Welch A, Schweiger L, Dahle-Smith A, Urquhart G, Finegan M, Petty RD.

Br J Cancer. 2015 Dec 1;113(11):1641. doi: 10.1038/bjc.2015.391. No abstract available. Erratum in: Br J Cancer. 2016 Jun 14;114(12):e18.

32.

Regulation of cellular sphingosine-1-phosphate by sphingosine kinase 1 and sphingosine-1-phopshate lyase determines chemotherapy resistance in gastroesophageal cancer.

Matula K, Collie-Duguid E, Murray G, Parikh K, Grabsch H, Tan P, Lalwani S, Garau R, Ong Y, Bain G, Smith AD, Urquhart G, Bielawski J, Finnegan M, Petty R.

BMC Cancer. 2015 Oct 22;15:762. doi: 10.1186/s12885-015-1718-7.

33.

Epidermal Growth Factor (EGFR) copy number aberrations in esophageal and gastro-esophageal junctional carcinoma.

Dahle-Smith Å, Stevenson D, Massie D, Murray GI, Dutton SJ, Roberts C, Ferry D, Osborne A, Clark C, Petty RD, Miedzybrodzka Z.

Mol Cytogenet. 2015 Oct 17;8:78. doi: 10.1186/s13039-015-0181-0. eCollection 2015.

34.

Biomarkers and novel agents in esophago-gastric cancer: are we making progress?

Dahle-Smith A, Petty RD.

Expert Rev Anticancer Ther. 2015;15(9):1103-19. doi: 10.1586/14737140.2015.1071669. Epub 2015 Aug 2. Review.

PMID:
26313419
35.

Mutations in GMPPB cause congenital myasthenic syndrome and bridge myasthenic disorders with dystroglycanopathies.

Belaya K, Rodríguez Cruz PM, Liu WW, Maxwell S, McGowan S, Farrugia ME, Petty R, Walls TJ, Sedghi M, Basiri K, Yue WW, Sarkozy A, Bertoli M, Pitt M, Kennett R, Schaefer A, Bushby K, Parton M, Lochmüller H, Palace J, Muntoni F, Beeson D.

Brain. 2015 Sep;138(Pt 9):2493-504. doi: 10.1093/brain/awv185. Epub 2015 Jun 30.

36.

Mutational spectrum and phenotypic variability of VCP-related neurological disease in the UK.

Figueroa-Bonaparte S, Hudson J, Barresi R, Polvikoski T, Williams T, Töpf A, Harris E, Hilton-Jones D, Petty R, Willis TA, Longman C, Dougan CF, Parton MJ, Hanna MG, Quinlivan R, Farrugia ME, Guglieri M, Bushby K, Straub V, Lochmüller H, Evangelista T.

J Neurol Neurosurg Psychiatry. 2016 Jun;87(6):680-1. doi: 10.1136/jnnp-2015-310362. Epub 2015 Jun 23. No abstract available.

37.

The risk and nature of flares in juvenile idiopathic arthritis: results from the ReACCh-Out cohort.

Guzman J, Oen K, Huber AM, Watanabe Duffy K, Boire G, Shiff N, Berard RA, Levy DM, Stringer E, Scuccimarri R, Morishita K, Johnson N, Cabral DA, Rosenberg AM, Larché M, Dancey P, Petty RE, Laxer RM, Silverman E, Miettunen P, Chetaille AL, Haddad E, Houghton K, Spiegel L, Turvey SE, Schmeling H, Lang B, Ellsworth J, Ramsey SE, Bruns A, Roth J, Campillo S, Benseler S, Chédeville G, Schneider R, Tse SM, Bolaria R, Gross K, Feldman B, Feldman D, Cameron B, Jurencak R, Dorval J, LeBlanc C, St Cyr C, Gibbon M, Yeung RS, Duffy CM, Tucker LB; ReACCh-Out investigators.

Ann Rheum Dis. 2016 Jun;75(6):1092-8. doi: 10.1136/annrheumdis-2014-207164. Epub 2015 May 18.

PMID:
25985972
38.

Novel MTND1 mutations cause isolated exercise intolerance, complex I deficiency and increased assembly factor expression.

Gorman GS, Blakely EL, Hornig-Do HT, Tuppen HA, Greaves LC, He L, Baker A, Falkous G, Newman J, Trenell MI, Lecky B, Petty RK, Turnbull DM, McFarland R, Taylor RW.

Clin Sci (Lond). 2015 Jun;128(12):895-904. doi: 10.1042/CS20140705.

39.

Dysregulation of autophagy in human follicular lymphoma is independent of overexpression of BCL-2.

McCarthy A, Marzec J, Clear A, Petty RD, Coutinho R, Matthews J, Wilson A, Iqbal S, Calaminici M, Gribben JG, Jia L.

Oncotarget. 2014 Nov 30;5(22):11653-68.

40.

Emotion and persuasion: cognitive and meta-cognitive processes impact attitudes.

Petty RE, Briñol P.

Cogn Emot. 2015;29(1):1-26. doi: 10.1080/02699931.2014.967183. Epub 2014 Oct 10. Review.

PMID:
25302943
41.

What matters most for patients, parents, and clinicians in the course of juvenile idiopathic arthritis? A qualitative study.

Guzman J, Gómez-Ramírez O, Jurencak R, Shiff NJ, Berard RA, Duffy CM, Oen K, Petty RE, Benseler SM, Brant R, Tucker LB.

J Rheumatol. 2014 Nov;41(11):2260-9. doi: 10.3899/jrheum.131536. Epub 2014 Sep 15.

PMID:
25225279
42.

Binding interactions between the encephalomyocarditis virus leader and protein 2A.

Petty RV, Basta HA, Bacot-Davis VR, Brown BA, Palmenberg AC.

J Virol. 2014 Nov;88(22):13503-9. doi: 10.1128/JVI.02148-14. Epub 2014 Sep 10.

43.

National evaluation of prescriber drug dispensing.

Munger MA, Ruble JH, Nelson SD, Ranker L, Petty RC, Silverstein S, Barton E, Feehan M.

Pharmacotherapy. 2014 Oct;34(10):1012-21. doi: 10.1002/phar.1461. Epub 2014 Jul 23.

PMID:
25053590
44.

Gefitinib for oesophageal cancer progressing after chemotherapy (COG): a phase 3, multicentre, double-blind, placebo-controlled randomised trial.

Dutton SJ, Ferry DR, Blazeby JM, Abbas H, Dahle-Smith A, Mansoor W, Thompson J, Harrison M, Chatterjee A, Falk S, Garcia-Alonso A, Fyfe DW, Hubner RA, Gamble T, Peachey L, Davoudianfar M, Pearson SR, Julier P, Jankowski J, Kerr R, Petty RD.

Lancet Oncol. 2014 Jul;15(8):894-904. doi: 10.1016/S1470-2045(14)70024-5. Epub 2014 Jun 17.

PMID:
24950987
45.

Early atlantoaxial subluxation in enthesitis-related arthritis.

Enazi AA, Morishita K, Cairns RA, Tucker L, Cabral D, Petty R, Guzman J.

J Rheumatol. 2014 Jun;41(6):1190-1. doi: 10.3899/jrheum.131206. No abstract available.

PMID:
24882848
46.

The outcomes of juvenile idiopathic arthritis in children managed with contemporary treatments: results from the ReACCh-Out cohort.

Guzman J, Oen K, Tucker LB, Huber AM, Shiff N, Boire G, Scuccimarri R, Berard R, Tse SM, Morishita K, Stringer E, Johnson N, Levy DM, Duffy KW, Cabral DA, Rosenberg AM, Larché M, Dancey P, Petty RE, Laxer RM, Silverman E, Miettunen P, Chetaille AL, Haddad E, Houghton K, Spiegel L, Turvey SE, Schmeling H, Lang B, Ellsworth J, Ramsey S, Bruns A, Campillo S, Benseler S, Chédeville G, Schneider R, Yeung R, Duffy CM; ReACCh-Out investigators.

Ann Rheum Dis. 2015 Oct;74(10):1854-60. doi: 10.1136/annrheumdis-2014-205372. Epub 2014 May 19.

PMID:
24842571
47.

Two recurrent mutations are associated with GNE myopathy in the North of Britain.

Chaouch A, Brennan KM, Hudson J, Longman C, McConville J, Morrison PJ, Farrugia ME, Petty R, Stewart W, Norwood F, Horvath R, Chinnery PF, Costigan D, Winer J, Polvikoski T, Healy E, Sarkozy A, Evangelista T, Pogoryelova O, Eagle M, Bushby K, Straub V, Lochmüller H.

J Neurol Neurosurg Psychiatry. 2014 Dec;85(12):1359-65. doi: 10.1136/jnnp-2013-306314. Epub 2014 Apr 2.

PMID:
24695763
48.

Tumour expression of leptin is associated with chemotherapy resistance and therapy-independent prognosis in gastro-oesophageal adenocarcinomas.

Bain GH, Collie-Duguid E, Murray GI, Gilbert FJ, Denison A, McKiddie F, Ahearn T, Fleming I, Leeds J, Phull P, Park K, Nanthakumaran S, Matula KM, Grabsch HI, Tan P, Welch A, Schweiger L, Dahle-Smith A, Urquhart G, Finegan M, Petty RD.

Br J Cancer. 2014 Mar 18;110(6):1525-34. doi: 10.1038/bjc.2014.45. Epub 2014 Feb 25. Erratum in: Br J Cancer. 2015 Dec 1;113(11):1641. Matula, K M [added].

49.

Serpin b3 is associated with poor survival after chemotherapy and is a potential novel predictive biomarker in advanced non-small-cell lung cancer.

Urquhart G, Kerr KM, Nicolson M, Loo PS, Sharma R, Shrimali R, Petty RD.

J Thorac Oncol. 2013 Dec;8(12):1502-9. doi: 10.1097/JTO.0000000000000016.

50.

A multicentre postal survey investigating the contribution of illness perceptions, coping and optimism to quality of life and mood in adults with muscle disease.

Graham CD, Weinman J, Sadjadi R, Chalder T, Petty R, Hanna MG, Turner C, Parton M, Maddison P, Radunovic A, Longman C, Robb Y, Bushby K, Hilton-Jones D, Rose MR.

Clin Rehabil. 2014 May;28(5):508-19. doi: 10.1177/0269215513511340. Epub 2013 Nov 15.

PMID:
24240060

Supplemental Content

Support Center